Skip to Main Content

Paper Details

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.
J Am Heart Assoc
6
2023
AF, Atrial Fibrillation, IPE, Icosapent Ethyl, Patients, atrial fibrillation, atrial flutter, cardiovascular death, icosapent ethyl, myocardial infarction, patients, stroke, unstable angina
Author NameAffiliation
Deepak L BhattMount Sinai Heart Icahn School of Medicine at Mount Sinai Health System New York NY USA.
Jean-Claude TardifMontreal Heart Institute, Universite de Montreal Montreal Quebec Canada.
Christie M BallantyneDepartment of Medicine Baylor College of Medicine Houston TX USA.
Christie M BallantyneDepartment of Medicine Baylor College of Medicine Houston TX USA.
  • 1 - 4

Datasets

Release 1.2